Åsa Lommelé

Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study

N. Sheerin, C. Licht, E. Rondeau, 2019, BMC Nephrology.

Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome.

G. Ardissino, G. Ariceta, F. Schaefer, 2018, Kidney international.

Comparative efficacy of ravulizumab and eculizumab in the treatment of atypical hemolytic uremic syndrome: An indirect comparison using clinical trial data

N. Freemantle, K. Deighton, N. Sheerin, 2021, Clinical nephrology.

Outcomes of patients with atypical haemolytic uraemic syndrome with native and transplanted kidneys treated with eculizumab: a pooled post hoc analysis

G. Remuzzi, T. Feldkamp, N. Sheerin, 2017, Transplant international : official journal of the European Society for Organ Transplantation.